Press & News

People are different and so is their cancer, patients should be treated individually.

2cureX holds a virtual live-session on the 26th of November 2021 to present and discuss the Interim report for the third quarter of 2021.

November 23, 2021

IR

2cureX releases the Interim report for the third quarter of 2021 on the 25th of November 2021 and on the 26th of November CEO Fernando Andreu, Ole Thastrup (CSO) and Kenneth G. Johansen (CFO) will present and discuss the report and provide a status of the European roll-out of 2cureX’s first IndiTreat product in metastatic colorectal cancer.

Please join us on the Webinar on the 26th of November at 13:00 (CET).

Link for registration: https://www.2curex.com/2curex-webinar-registration-q3-2021/